Are you working on challenging targets that don’t have enough data to feed conventional AI drug design engines? What if you could simultaneously optimize your compounds for desired efficacy, specificity, and synthesizability – without needing abundant historic data?
With YDS Pharmatech’s drug discovery platform -MERES- you can achieve lead candidates in 8 weeks with as little as one molecule as input.
MERES, short for modify-evaluate-reinforce-evolve-sampling, is our unique proprietary AI plus biophysics drug design engine that has already accelerated programs for biopharma partners, increased a PROTAC candidate binding to a challenging target by 100-fold, discovered the world’s first alphavirus inhibitor, and generated new IP for an allosteric kinase inhibitor.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1220 Washington Ave, Albany, Ny 12226, Etec
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.yds-pharmatech.com
- Keywords
- Paris.
- HQ
- Albany, New York
Yds Pharmatech Questions
Yds Pharmatech's website is http://www.yds-pharmatech.com
Yds Pharmatech's LinkedIn profile is https://www.linkedin.com/company/yds-pharmatech
Yds Pharmatech has
4 employees.
View email and phone details for 4
employees at Yds Pharmatech.
Yds Pharmatech's industry is
Biotechnology Research
Yds Pharmatech's top competitors are
Kinentia Biosciences,
Humonix Biosciences, Inc.,
Anotech,
Apheon Bioscience,
Chai Discovery,
Atommap,
Biomed Innova,
Pisa Biopharm Inc,
N1 Life,
Taconic Biosciences.
Yds Pharmatech's categories are Biotechnology Research
Yds Pharmatech's founding year is 2020
